Improving HIV testing, linkage, and retention in care for men through U=U messaging
Improving HIV testing, linkage, and retention in care for men through U=U messaging
批准号:
10483486
负责人:
Alison Meredith Buttenheim
金额:
$59.2万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-06-01 至 2027-04-30
关键词:
AIDS preventionAchievementAcquired Immunodeficiency SyndromeAddressAdherenceAdoptionAfrica South of the SaharaAnxietyAreaBehavioral SciencesCaringClinicCollaborationsCommunicable DiseasesCommunitiesContinuity of Patient CareCounselingCountryCoupledDataEffectivenessEffectiveness of InterventionsEpidemicEpidemiologyEvaluationFrightGenderGoalsGovernmentGuidelinesHIVHIV InfectionsHIV SeropositivityHealthHealth BenefitHigh PrevalenceHuman immunodeficiency virus testIncidenceIncomeInterventionKnowledgeLearningMethodsOutcomeParticipantPenetrationPersonsPrevalenceProcessProvinceRandomizedResearchResourcesSafe SexSexual PartnersShapesSiteSouth AfricaTestingUnsafe SexViralViral Load resultWomanWorkantiretroviral therapybasebehavioral economicscis-maleclinical practicecontextual factorseffectiveness evaluationeffectiveness-implementation RCTexperiencefuture implementationhuman centered designimplementation barriersimplementation effortsimplementation facilitationimprovedinnovationinsightmale healthmenmortality riskpeerprimary outcomeprototyperandomized trialsecondary outcomeservice deliveryservice uptakesexual HIV transmissionstandard of caresuccessful interventiontesting servicestesting uptaketheoriestherapy adherencetooltreatment adherencetreatment as preventionuptakeyeast two hybrid system
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT ABSTRACT
Increasing the coverage of HIV testing and treatment among people living with HIV (PLHIV) is essential for
ending the global AIDS epidemic. Unfortunately, compared to women, men living with HIV (MLHIV) are less
likely to know their HIV status, start anti-retroviral treatment, or achieve viral suppression. Given that new HIV
infections among women are driven, in part, by men’s testing and treatment gaps, reducing the gender gap in
testing uptake, treatment initiation and achievement of viral suppression by men must be prioritized in order to
accelerate the decline in HIV incidence among women, improve men’s HIV-related health outcomes and achieve
the UNAIDS 95-95-95 goals by 2030. In this study, we evaluate the effectiveness of Undetectable Equals
Untransmittable or “U=U” messaging for closing the gender gap in the HIV cascade. The U=U message
communicates the compelling idea that PLHIV who take ART and have an undetectable viral load (<200
copies/mL) cannot sexually transmit HIV. Particularly for men, the U=U message has the potential to accelerate
progress towards the 95-95-95 targets by: 1) reducing anxiety associated with HIV testing (1st 95); 2) encouraging
people who test HIV-positive to initiate ART (2nd 95); and 3) reducing fear of transmitting HIV to sexual partners
by promoting treatment adherence to achieve viral suppression (3rd 95). While there is a growing knowledge of
Treatment as Prevention (TasP)/U=U among PLWH in Western countries, the reach and penetration of the U=U
message in sub-Saharan Africa has been limited and few studies have tested the impacted of accessible U=U
messages on ART uptake and adherence in sub-Saharan Africa. Building on our prior work on U=U messaging
informed by behavioral economics and human-centered design, we propose to conduct two hybrid type 1
effectiveness-implementation randomized controlled trials to evaluate the impact of U=U messages on men’s
uptake of community-based HIV testing and treatment initiation (Aim 1), and achievement of viral suppression
(Aim 2). We will also conduct a multi-method evaluation to inform future implementation of U=U messaging
interventions. To improve the generalizability of our findings, we will conduct our study in two provinces in South
Africa (Western and Eastern Cape). If effective, our intervention can shape global HIV testing and treatment
counselling guidelines and practices. Our expert, multi-institutional collaborations will allow us to apply previous
research findings, leverage unique implementation platforms and resources, and rapidly disseminate our
findings.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inoculating and boosting against HIV vaccine misinformation among adolescent girls and young women in South Africa
-
批准号:10620056
-
项目类别:
-
资助金额:$64.55万
-
财政年份:2023
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Improving HIV testing, linkage, and retention in care for men through U=U messaging
-
批准号:10626959
-
项目类别:
-
资助金额:$54.37万
-
财政年份:2022
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Research Program
-
批准号:10460466
-
项目类别:
-
资助金额:$65.46万
-
财政年份:2020
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Research Program
-
批准号:10225990
-
项目类别:
-
资助金额:$66.76万
-
财政年份:2020
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Research Program
-
批准号:10683409
-
项目类别:
-
资助金额:$62.33万
-
财政年份:2020
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Improving participation in vector control campaigns
-
批准号:8759325
-
项目类别:
-
资助金额:$56.56万
-
财政年份:2014
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Improving participation in vector control campaigns
-
批准号:8917290
-
项目类别:
-
资助金额:$52.26万
-
财政年份:2014
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Vaccination status of children exempted from school-entry immunization mandates
-
批准号:8750180
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2014
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Improving participation in vector control campaigns
-
批准号:9091592
-
项目类别:
-
资助金额:$50.66万
-
财政年份:2014
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Improving participation in vector control campaigns
-
批准号:9318573
-
项目类别:
-
资助金额:$51.21万
-
财政年份:2014
-
负责人:Alison Meredith Buttenheim
-
依托单位:
Methods Core
-
批准号:9376072
-
项目类别:
-
资助金额:$24.37万
-
财政年份:--
-
负责人:Alison Meredith Buttenheim
-
依托单位:
海外基金